Macrocyclic Peptide Solution-Phase Synthesis and Filtration Deprotection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing solid-phase synthesis methods for the compound of formula (Ia) are not suitable for industrial-scale manufacturing due to low yields, long reaction times, and epimerization issues, making them unsuitable for large-scale production under GMP conditions.
Innovation Solution
A solution-phase process is developed for manufacturing compounds of formula (I), using specific reagents and solvents to minimize epimerization and improve yields, along with a novel method for Fmoc deprotection through filtration rather than aqueous washing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If solid-phase synthesis is used for manufacturing compound (Ia), then the synthesis can be performed in a controlled manner, but the yields are low and reaction times are long making it unsuitable for industrial scale
Solution Approach 1:
The patent changes the fundamental parameter of the synthesis medium from solid-phase to solution-phase, enabling industrial-scale manufacturing with improved yields and reduced reaction times while maintaining stereochemical integrity
Solution Approach 2:
The patent replaces the mechanical solid-phase support system with a solution-phase chemical system, substituting physical constraints with chemical reactivity to achieve better manufacturing outcomes
2Ease of manufacture
If solid-phase synthesis is used for compound (Ia), then the synthesis can proceed with standard protocols, but epimerization of stereocentres occurs reducing product quality
Solution Approach 1:
The patent changes the reaction medium parameter from solid-phase to solution-phase, which fundamentally alters the reaction environment to prevent epimerization while maintaining ease of manufacture through optimized solution conditions
Solution Approach 2:
The patent creates an inert solution-phase environment that protects stereocentres from epimerization, analogous to creating an inert atmospheric protection, ensuring stereochemical integrity throughout the synthesis process
3Reliability
If conventional Fmoc deprotection with aqueous washing is used, then the deprotection can be achieved, but the process is cumbersome for large-scale manufacturing
Solution Approach 1:
The patent extracts and removes the cumbersome aqueous washing step from the Fmoc deprotection process, replacing it with a simplified filtration method that maintains deprotection efficiency while dramatically reducing process complexity for scale-up
Solution Approach 2:
The patent creates an alternative deprotection pathway that copies the essential function of Fmoc removal but eliminates the problematic aqueous washing step, achieving the same result through a different mechanistic approach
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves high yields with low epimerization levels, suitable for large-scale manufacturing under GMP conditions, providing a reliable and efficient method for producing compounds of formula (I).
Implementation Method 1
The reaction mixture was concentrated under reduced pressure to afford the title compound
Data Source
AI summary
The invention provides a novel process for manufacturing a compound of formula (I), or a salt thereof,wherein PG1, PG2 and PG3 are amino protective groups. The process according to the invention is particularly suitable for large-scale manufacturing under GMP conditions.